Citation: P. Stadler et al., A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy, STRAH ONKOL, 176(2), 2000, pp. 98-98
Authors:
Becker, A
Stadler, P
Krause, U
Kuhnt, T
Hansgen, G
Dettmar, P
Feldmann, HJ
Rath, FW
Molls, M
Dunst, J
Citation: A. Becker et al., No association between p53-overexpression and polarographically measured tumor oxygenation in patients with head and neck carcinomas, STRAH ONKOL, 176(10), 2000, pp. 475-480
Authors:
Geinitz, H
Zimmermann, FB
Stoll, P
Narkwong, L
Kneschaurek, P
Busch, R
Kuzmany, A
Molls, M
Citation: H. Geinitz et al., Value of dose-volume histograms in estimating rectal bleeding after conformal radiotherapy for prostate cancer, FRONT RAD T, 34, 2000, pp. 177-185
Authors:
Huber, R
Braselmann, H
Kulka, U
Schumacher-Georgiadou, V
Bayerl, A
Molls, M
Bauchinger, M
Citation: R. Huber et al., Follow-up analysis of translocation and dicentric frequencies, measured byFISH-chromosome painting in breast cancer patients after partial-body radiotherapy with little bone marrow exposure, MUT RES-GTE, 446(1), 1999, pp. 103-109
Authors:
Bremer, M
Neuhofer, C
Auberger, T
Zimmermann, FB
Kneschaurek, P
Reuschel, W
Molls, M
Citation: M. Bremer et al., Palliative radiotherapy of malignant melanoma with reactor fission neutrontherapy (RENT): A prospective study, RADIAT ON I, 7(2), 1999, pp. 118-124
Authors:
Stadler, P
Becker, A
Feldmann, HJ
Hansgen, G
Dunst, J
Wurschmidt, F
Molls, M
Citation: P. Stadler et al., Influence of the hypoxic subvolume on the survival of patients with head and neck cancer, INT J RAD O, 44(4), 1999, pp. 749-754
Citation: H. Geinitz et al., Radiation therapy in old patients. Side effects and results of radiation therapy in old patients, STRAH ONKOL, 175(3), 1999, pp. 119-127
Authors:
Auberger, T
Thurriegl, B
Freude, T
Weissfloch, L
Senekowitsch-Schmidke, R
Kneschaurek, P
Wagner, FM
Molls, M
Citation: T. Auberger et al., Oxygen tension in transplanted mouse osteosarcomas during fractionated high-LET- and low-LET radiotherapy - Predictive aspects for choosing beam quality?, STRAH ONKOL, 175, 1999, pp. 52-56
Authors:
Holz, FG
Engenhart-Cabillic, R
Unnebrink, K
Pritsch, M
Bellmann, C
Debus, J
Volcker, HE
Wannenmacher, M
Schmitt, J
Holle, R
Muller, RP
Wolfensberger, TJ
Schutt, F
Staudt, S
Taufenbach, D
Gross-Jendroska, M
Potthofer, S
Bornfeld, N
Kleineidam, M
Behme, T
Foerster, M
Wiegel, T
Hinkelbein, W
Schonherr, U
Amann, T
Mardin, CY
Naumann, GOH
Schuchardt, U
Keilholz, L
Sauer, R
Hansen, LL
Scheuerbrandt, M
Jahnknecht, P
Schlunck, G
Henne, K
Frommhold, H
Winter, R
Steinhorst, U
Steiner, M
de Groot, H
Placke, F
Rades, D
Karstens, JH
Fuss, M
Scheider, A
Ulbig, MW
Roesen, B
Kampik, A
Feldmann, KJ
Grosu, AL
Molls, M
Pauleikhoff, D
Radermacher, M
Spital, G
Muller, C
Hobin, L
Schafer, U
Riesenbeck, D
Willich, N
Bunse, A
Ottmann, S
Gabel, P
Allgauer, M
Rube, L
Herbst, M
Atzinger, A
Schrader, WF
Fischer, P
Flentje, M
Herrmann, A
Citation: Fg. Holz et al., A prospective, randomized, double-masked trial on radiation therapy for neovascular age-related macular degeneration (RAD study), OPHTHALMOL, 106(12), 1999, pp. 2239-2247
Citation: M. Molls et al., Hemoglobin Level and Tumor Oxygenation - Symposium held at the Congress ofthe German Cancer Society Berlin, 10 June 1998, STRAH ONKOL, 174, 1998, pp. 1-1
Authors:
Molls, M
Stadler, P
Becker, A
Feldmann, HJ
Dunst, J
Citation: M. Molls et al., Relevance of oxygen in radiation oncology - Mechanisms of action, correlation to low hemoglobin levels, STRAH ONKOL, 174, 1998, pp. 13-16